Related references
Note: Only part of the references are listed.EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer et al.
ARTHRITIS & RHEUMATOLOGY (2019)
A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome
Sebastian Udry et al.
IMMUNOLOGIC RESEARCH (2019)
High prevalence of antinuclear antibodies in patients following venous thromboembolism
Joanna Natorska et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Antiphospholipid syndrome
Karen Schreiber et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry
Ignasi Rodriguez-Pinto et al.
AUTOIMMUNITY REVIEWS (2016)
What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?
Tzu-Fei Wang et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome
Cristina Belizna
AUTOIMMUNITY REVIEWS (2015)
The relevance of non-criteria clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features
Mirhelen M. Abreu et al.
AUTOIMMUNITY REVIEWS (2015)
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study
Arsene Mekinian et al.
AUTOIMMUNITY REVIEWS (2015)
Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study
P. Mustonen et al.
LUPUS (2014)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Laboratory and Clinical Features of Pregnant Women With Antiphospholipid Syndrome and Neonatal Outcome
A. Ruffatti et al.
ARTHRITIS CARE & RESEARCH (2010)
Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Livedo reticularis as a criterion for antiphospholipid syndrome
E. Toubi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Primary antiphospholipid syndrome: A distinct entity?
C Mackworth-Young
AUTOIMMUNITY REVIEWS (2006)
Long-term follow-up in 128 patients with primary antiphospholipid syndrome -: Do they develop lupus?
JA Gómez-Puerta et al.
MEDICINE (2005)
Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
R Cervera et al.
ARTHRITIS AND RHEUMATISM (2002)
Autoantibody studies of female patients with reproductive failure
K Reimand et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2001)
Share Paper
